Skip to main content

Ginkgo Bioworks Hldgs Inc(DNA-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low6.26
Day High6.67
Open:6.58
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Top Stories: Ginkgo Bioworks Hldgs Inc

Select a category then submit the form to load news
Ginkgo Bioworks Bets on Autonomous Labs Amid Headwinds
Ginkgo Bioworks Divests Biosecurity Unit, Retains Minority Stake
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA) and Xenon (XENE)
Ginkgo Bioworks realigns leadership, shifts COO responsibilities
Analysts Have Conflicting Sentiments on These Healthcare Companies: NewAmsterdam Pharma Company (NAMS), Emergent Biosolutions (EBS) and Ginkgo Bioworks Holdings (DNA)
Bank of America Securities Remains a Sell on Ginkgo Bioworks Holdings (DNA)
Ginkgo Bioworks Earnings Call: Mixed Sentiments and Strategic Moves
Ginkgo Bioworks Reports Q3 2025 Financial Results
Ginkgo Bioworks Enters Sales Agreement for Stock Offering
Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium
Ginkgo Bioworks Settles Stockholder Derivative Actions
BTIG Sticks to Its Sell Rating for Ginkgo Bioworks Holdings (DNA)
Ginkgo Bioworks Earnings Call: Mixed Sentiment and Strategic Growth
Ginkgo Bioworks awarded $4.66M contract by PNNL
Ginkgo Bioworks Holdings (DNA) Receives a Buy from TD Cowen
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA) and Elanco Animal Health (ELAN)
Analysts Conflicted on These Healthcare Names: Merus (MRUS), Ginkgo Bioworks Holdings (DNA) and Embecta Corporation (EMBC)
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), Teva Pharmaceutical (TEVA) and Medtronic (MDT)
BTIG Reaffirms Their Sell Rating on Ginkgo Bioworks Holdings (DNA)

Profile

Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.